Five-year outcomes in patients with chronic total coronary occlusion treated with drug-eluting vs bare-metal stents: A case-control study

Canadian Journal of Cardiology

Volumn 29, Issue 8, 2013, Pages 945-950

  De Felice, Francesco ^a   Fiorilli, Rosario ^a   Parma, Antonio ^a   Musto, Carmine ^a   Nazzaro, Marco Stefano ^a   Scappaticci, Massimiliano ^a   Confessore, Pierpaolo ^a   Guerra, Elena ^a   Belloni, Flavia ^b   Violini, Roberto ^a  

^a SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^b SPIRITO SANTO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BARE METAL STENT; CASE CONTROL STUDY; CONTROLLED STUDY; DEATH; DRUG ELUTING STENT; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HEART DEATH; HEART DISEASE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; STENT THROMBOSIS; SURVIVAL;

AGED; CASE-CONTROL STUDIES; CHRONIC DISEASE; CORONARY OCCLUSION; CORONARY VESSELS; DISEASE-FREE SURVIVAL; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; STENTS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 84881024210     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2012.10.002     Document Type: Article

References (16)

1. Ge L., Iakovou I., Cosgrave J., et al. Immediate and mid-term outcomes of sirolimus-eluting stent implantation for chronic total occlusions. Eur Heart J 2005, 26:1056-1062.
2. Werner G.S., Krack A., Schwarz G., et al. Prevention of lesion recurrence in chronic total coronary occlusions by paclitaxel-eluting stents. JAm Coll Cardiol 2004, 44:2301-2306.
3. Suttorp M.J., Laarman G.J., Rahel B.M., et al. Primary Stenting of Totally Occluded Native Coronary Arteries II (PRISON II): a randomized comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions. Circulation 2006, 114:921-928.
4. De Felice F., Fiorilli R., Parma A., et al. Clinical outcome of patients with chronic total occlusion treated with drug eluting stents. Int J Cardiol 2009, 132:337-341.
5. De Felice F., Fiorilli R., Parma A., et al. Clinical outcome of patients with diabetes mellitus and chronic total occlusion treated with drug-eluting stents. JInvasive Cardiol 2008, 20:651-654.
6. Garcia-Garcia H.M., Daemen J., Kukreja N., et al. Three-year clinical outcomes after coronary stenting of chronic total occlusion using sirolimus-eluting stent. Catether Cardiovasc Interv 2007, 70:635-639.
7. Rahel M.B., Laarman G.J., Kelder J.C., Ten Berg J.M., Suttorp M.J. Three-year clinical outcome after primary stenting of totally occluded native coronary arteries: a randomized comparison of bare-metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions (PRISON II study). Am Heart J 2009, 157:149-155.
8. De Felice F., Fiorilli R., Parma A., et al. 3-year clinical outcome of patients with chronic total occlusion treated with drug eluting stents. JAm Coll Cardiol Interv 2009, 2:1260-1265.
9. Shen Z.J., García-García H.M., Garg S., et al. Five-year clinical outcomes after coronary stenting of chronic total occlusion using sirolimus-eluting stents: insights from the rapamycin-eluting stent evaluated at Rotterdam Cardiology Hospital-(Research) Registry. Catheter Cardiovasc Interv 2009, 74:979-986. Interventional Cardiologists at Thoraxcentre in 2000-2003.
10. Van den Branden B.J.L., Rahel B.M., Laarman G.J., et al. Five-year clinical outcome after primary stenting of totally occluded native coronary arteries: a randomised comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary total occlusions (PRISON II study). Eurointervention 2012, 7:1189-1196.
11. Cutlip D.E., Windecker S., Mehran R., Academic Research Consortium, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007, 115:2344-2351.
12. Colmenarez H.J., Escaned J., Fernández C., et al. Efficacy and safety of drug-eluting stents in chronic total coronary occlusion recanalization: a systematic review and meta-analysis. JAm Coll Cardiol 2010, 55:1854-1866.
13. Pfisterer M., Brunner-La Rocca H.P., Buser P.T., BASKET-LATE Investigators, et al. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. JAm Coll Cardiol 2006, 48:2584-2591.
14. Spaulding C., Daemen J., Boersma E., Cutlip D.E., Serruys P.W. Apooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. NEngl J Med 2007, 356:989-997.
15. Räber L., Wohlwend L., Wigger M., et al. Five-year clinical and angiographic outcomes of a randomized comparison of sirolimus-eluting and paclitaxel-eluting stents: results of the Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization LATE trial. Circulation 2011, 123:2819-2828.
16. Khouzam R.N., Shaheen M., Aziz R.K., Ibebuogu U.N. The important role of inflammatory biomarkers pre and post bare-metal and drug-eluting stent implantation. Can J Cardiol 2012, 28:700-705.